Coramsine Injection. 1.5mg/kg infused over 4 hours, daily for 5 days. Six cycles.

2 trials

Sponsors

Solbec Pharmaceuticals Ltd

Phase 2

An Open Label, Multi Centre, Phase II Study to Evaluate the Safety and Efficacy of Coramsine Injection in Patients with Renal Cell Carcinoma

Not yet recruitingACTRN12606000099527

Solbec Pharmaceuticals Ltd

Start: 2006-06-30Target: 56Updated: 2020-01-13

An Open Label, Multi Centre, Phase II Study to Evaluate the Safety and Efficacy of Coramsine Injection in Patients with Melanoma

Not yet recruitingACTRN12606000330549

Solbec Pharmaceuticals Ltd

Start: 2006-10-01Target: 56Updated: 2020-01-13